Physician profile
Joy Ellen Silver
NPI 1811941669
$1,651.19
in general payments reported to CMS, 2019-2025
17 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $197 · 2021: $231 · 2022: $237 · 2023: $285 · 2024: $292 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $326.11 | 2019-2024 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $262.41 | 2023-2025 | Qelbree, Qelbree |
| Cranial Technologies, INC | $208.47 | 2019-2024 | Doc Band |
| Kaleo, INC. | $144.19 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $137.67 | 2019-2024 | |
| Sobi, INC | $121.77 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $98.16 | 2019-2023 | Vaxelis, Vaxneuvance, Rotateq |
| Takeda Pharmaceuticals U.S.A., INC. | $83.02 | 2019-2021 | |
| Corium, LLC | $52.94 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $45.91 | 2019-2020 | |
| Seqirus USA INC | $41.55 | 2024-2025 | Flucelvax |
| Sanofi Pasteur INC. | $35.31 | 2023 | |
| Neos Therapeutics, LP | $29.15 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $24.59 | 2023 | Flumist Quadrivalent |
| Adlon Therapeutics L.P. | $14.74 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.87 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.